Published in Medical Device Law Weekly, March 6th, 2005
Ringrose brings more than 30 years of pharmaceutical industry experience and, according to the company, will strengthen Astex's board as the company prepares to take the first of its oncology drugs into the clinic during 2005.
Tim Haines, chief executive of Astex, said, "I am very pleased that Peter has accepted our invitation to join the Astex board. His track record in overseeing the research and development strategies of a number of global pharmaceutical companies and his in-depth understanding of the needs of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly